Skip to main content
OpenTrials

Clinical trial condition

Coronavirus Infections

Explore clinical trials studying Coronavirus Infections. Study availability and eligibility vary by location and protocol.

692 public trials 32 recruiting studies
Refine in advanced search Browse all conditions

Coronavirus Infections trial results

Completed

ACTIV-2: A Study for Outpatients With COVID-19

NCT04518410

Conditions
COVID-19, Coronaviridae Infections, Coronavirus, +12 more
Locations
  • Pinnacle Research Group (Site 1082), 321 E. 10th Street Anniston, Alabama, United States
  • North Alabama Research Center LLC (Site 1194), 721 W. Market St., Ste. B Athens, Alabama, United States
  • University of Alabama at Birmingham (Site 1005), 908 20th Street South Birmingham, Alabama, United States
  • Cullman Clinical Trials (Site 1140), 501 Clark St. NE. Cullman, Alabama, United States
View all 252 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine

NCT05519839

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Paratus Clinical Research - Canberra Bruce, Australian Capital Territory, Australia
  • Paratus Clinical Research - Western Sydney Blacktown, New South Wales, Australia
  • Emeritus Research - Sydney Botany, New South Wales, Australia
  • Genesis Central Coast Broadmeadow, New South Wales, Australia
View all 35 locations
View Trial Details
Completed

A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

NCT04860297

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Aventiv Research Inc Mesa, Arizona, United States
  • California Institute of Renal Research San Diego, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Tampa General Medical Group Tampa, Florida, United States
View all 15 locations
View Trial Details
Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

NCT05310084

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Northern Beaches Clinical Research Brookvale, New South Wales, Australia
  • Australian Clinical Research Network Sydney, New South Wales, Australia
  • Westmead Hospital Westmead, New South Wales, Australia
  • Paratus Clinical Research Brisbane Albion, Queensland, Australia
View all 26 locations
View Trial Details

Related conditions